Grants

Create a Grant

Filter:

All grants
Open
Closed
Awarded

New development of oHSV-Gluc biotechnology
Sponsored by Open Therapeutics™ on 2022-11-29 17:00 UTC
Open for proposal submissions from 2022-12-31 17:01 UTC and voting against this grant starts from 2023-02-01 01:00 UTC
Grant for the attendance at DeSci meeting, Amsterdam, 20 April 2022 Expired
Sponsored by Open Therapeutics™ on 2022-03-10 19:40 UTC
Closed for proposal submissions. and voting against this grant ended on 2022-06-15 22:00 UTC
Grant for the attendance at DAO Global Governance Gathering, Amsterdam, 18-19 April 2022 Expired
Sponsored by Open Therapeutics™ on 2022-03-10 17:00 UTC
Closed for proposal submissions. and voting against this grant ended on 2022-05-17 21:00 UTC
New development of oHSV for cancer treatment
Sponsored by Open Therapeutics™ on 2022-02-22 09:15 UTC
Open for proposal submissions from 2022-12-31 16:24 UTC and voting against this grant starts from 2023-04-01 00:00 UTC
Preclinical study of amphiphilic amines (RC16) for cancer treatment
Sponsored by Open Therapeutics™ on 2022-02-22 09:14 UTC
Open for proposal submissions from 2023-01-01 16:24 UTC and voting against this grant starts from 2023-04-09 00:00 UTC
Discovery of novel pathogenic bacterial essential proteins
Sponsored by Open Therapeutics™ on 2022-02-22 09:13 UTC
Open for proposal submissions from 2023-01-31 16:24 UTC and voting against this grant starts from 2023-03-19 00:00 UTC
Discovery of new targets for cancer immunotherapy
Sponsored by Open Therapeutics™ on 2022-02-22 09:12 UTC
Open for proposal submissions from 2023-02-28 16:24 UTC and voting against this grant starts from 2023-04-16 00:00 UTC
Animal study of Pseudomonas aeruginosa for cholesteatoma treatment
Sponsored by Open Therapeutics™ on 2022-02-22 09:11 UTC
Open for proposal submissions from 2023-02-28 16:24 UTC and voting against this grant starts from 2023-04-16 00:00 UTC
Develop 2nd generation microbial fuel cell: Pseudomonas aeruginosa for the killing of pathogens in electrogenic bioreactor
Sponsored by Open Therapeutics™ on 2022-02-22 09:11 UTC
Open for proposal submissions from 2023-03-31 15:24 UTC and voting against this grant starts from 2023-05-16 00:00 UTC
Further development Genetics Rights Management (GeRM) for controlling the release of microorganism
Sponsored by Open Therapeutics™ on 2022-02-22 09:10 UTC
Open for proposal submissions from 2023-05-01 15:24 UTC and voting against this grant starts from 2023-07-16 00:00 UTC

Recently awarded grants: